553 related articles for article (PubMed ID: 12855648)
1. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
[TBL] [Abstract][Full Text] [Related]
2. Cancer gene therapy using a survivin mutant adenovirus.
Mesri M; Wall NR; Li J; Kim RW; Altieri DC
J Clin Invest; 2001 Oct; 108(7):981-90. PubMed ID: 11581299
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity.
Ohashi H; Takagi H; Oh H; Suzuma K; Suzuma I; Miyamoto N; Uemura A; Watanabe D; Murakami T; Sugaya T; Fukamizu A; Honda Y
Circ Res; 2004 Apr; 94(6):785-93. PubMed ID: 14963002
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells.
Harfouche R; Hasséssian HM; Guo Y; Faivre V; Srikant CB; Yancopoulos GD; Hussain SN
Microvasc Res; 2002 Jul; 64(1):135-47. PubMed ID: 12074640
[TBL] [Abstract][Full Text] [Related]
6. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
[TBL] [Abstract][Full Text] [Related]
7. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
Singh RP; Dhanalakshmi S; Agarwal C; Agarwal R
Oncogene; 2005 Feb; 24(7):1188-202. PubMed ID: 15558015
[TBL] [Abstract][Full Text] [Related]
8. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
Zhang M; Latham DE; Delaney MA; Chakravarti A
Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
[TBL] [Abstract][Full Text] [Related]
11. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
[TBL] [Abstract][Full Text] [Related]
12. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.
Tomicic MT; Christmann M; Kaina B
J Pharmacol Exp Ther; 2010 Jan; 332(1):316-25. PubMed ID: 19812371
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer.
Li X; Marani M; Yu J; Nan B; Roth JA; Kagawa S; Fang B; Denner L; Marcelli M
Cancer Res; 2001 Jan; 61(1):186-91. PubMed ID: 11196158
[TBL] [Abstract][Full Text] [Related]
14. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.
Mesri M; Morales-Ruiz M; Ackermann EJ; Bennett CF; Pober JS; Sessa WC; Altieri DC
Am J Pathol; 2001 May; 158(5):1757-65. PubMed ID: 11337373
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic gene therapy: disruption of neovascular networks mediated by inducible caspase-9 delivered with a transcriptionally targeted adenoviral vector.
Song W; Sun Q; Dong Z; Spencer DM; Núñez G; Nör JE
Gene Ther; 2005 Feb; 12(4):320-9. PubMed ID: 15616606
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway.
Tomicic MT; Christmann M; Kaina B
Apoptosis; 2005 Dec; 10(6):1295-304. PubMed ID: 16215690
[TBL] [Abstract][Full Text] [Related]
17. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
18. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
Zi X; Simoneau AR
Cancer Res; 2005 Apr; 65(8):3479-86. PubMed ID: 15833884
[TBL] [Abstract][Full Text] [Related]
19. MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells.
Yang JS; Hour MJ; Huang WW; Lin KL; Kuo SC; Chung JG
J Pharmacol Exp Ther; 2010 Aug; 334(2):477-88. PubMed ID: 20463006
[TBL] [Abstract][Full Text] [Related]
20. p53-dependent apoptotic mechanism of a new designer bimetallic compound tri-phenyl tin benzimidazolethiol copper chloride (TPT-CuCl2): in vivo studies in Wistar rats as well as in vitro studies in human cervical cancer cells.
Höti N; Zhu DE; Song Z; Wu Z; Tabassum S; Wu M
J Pharmacol Exp Ther; 2004 Oct; 311(1):22-33. PubMed ID: 15173313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]